Nov 4, 2021 8:00 am EDT The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies, Inc. Read More
Nov 3, 2021 4:05 pm EDT Codexis and Nestlé Health Science Initiate a Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency Read More
Oct 21, 2021 4:05 pm EDT Codexis to Report Third Quarter 2021 Financial Results on November 4 Read More
Oct 18, 2021 8:00 am EDT Codexis, Almelo and RC2 Announce a Tri-Party Collaboration for the Enzymatic Production of Low Cost Sitagliptin API for the Generic Market, Including a License to Codexis Enzyme Technology in India Read More
Sep 9, 2021 4:05 pm EDT Codexis and Merck Amend and Extend Supply Agreement for Enzyme Used in Manufacture of Sitagliptin Read More
Aug 25, 2021 4:05 pm EDT Codexis Confirms Receipt of Follow-on Orders for Proprietary Enzyme Product from Undisclosed Global Pharmaceutical Company Read More
Jul 26, 2021 4:05 pm EDT Codexis and Kalsec Announce Expanded Collaboration for Supply of Novel Enzyme to Sustainably Produce Natural Clean-Label Beverage Ingredient Read More
Jul 22, 2021 4:05 pm EDT Codexis to Report Second Quarter 2021 Financial Results on August 5 Read More